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The large variations observed in "distal" bypass patency rates and the abuse of life-table analysis have encouraged most 
Vascular Committees todevelop standards for evaluating results. However, problems continue to persist. Some of these do 
not relate to statistical nalysis but to the lack of definition of both secondary patency and "distal" when referring to arterial 
bypass grafts to the lower limb. We present various problems and propose some strict definitions for each type of 
infrainguinal reconstruction, based on the inflow and outflow levels, together with a modification of the definitions of 
primary assisted and secondary patency. 
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Introduction 
Review of the literature on "distal" bypass demon- 
strates a wide variation in results 1-29 with patency 
rates ranging from 80% at 5 years to 12% at 2 years 
(Table 1). These large discrepancies suggest that some 
vascular surgeons may be highly selective with regard 
to choosing patients for surgery. The results of 
multicentre trials are significantly worse ~5 than the 
results published in individual uncontrolled 
82329 series,' • which also confirms this view. There are 
further problems which make comparison between 
different series almost impossible. 
Firstly, what does "distal" mean? The definition is 
controversial, being different on both sides of the 
Atlantic, but its usage may describe all infraingui- 
nal, 1-7 all infragenicular, 8-110r, all infra~o~litea114-17 
bypass grafts. The term tibial bypass 1"23-25 is some- 
times preferred in the U.S.A. to differentiate grafts to 
single calf vessels from grafts to the infragenicular 
popliteal artery and tibioperoneal trunk. However, 
many authors use the term "distal" indiscriminatel3~ 
and may include all or any of the following grafts: 
infrainguinal, infragenicular, infrapopliteal, crural or 
short crural/pedal bypass. 9'11 
Secondly, patency depends not only on the outflow 
*Please address all correspondence to: P. R. Taylor, Consultant 
Vascular Surgeon, Department of Surger3~ 2nd Floor, New Guys 
House, Guys Hospital St Thomas's Street, London SE1 9RT, U.K. 
site, but also on the inflow site, ~3'21 which determines 
the length of the graft and, therefore, the extent of its 
thrombogenic surface. The inflow site is also variable 
in most of the reports. In some, 2'21 the common 
femoral artery was used for all grafts while in others 
30% originated from the popliteal artery. 9These short 
grafts would be expected to be associated with better 
patency rates than long grafts (> 70 cm). 29 
Third134 problems arise from differences in the 
indication for reconstruction. Some reports include 
only grafts undertaken for critical limb ischaemia 
(CLI), 19'21-25 while others include claudicants in their 
analysis. 1-~1 This may also be related to the aggres- 
siveness of the surgical policy employed by the 
surgeon. For example, some may attempt distal 
reconstruction i all cases presenting with CLI, graft- 
ing to blind segments with no straight flow to the 
foot. 36 
Others recommend primary amputation in such 
cases, especially when no vein is available. 37 Fourthly, 
5 9 11 19 26-29 some series comprise veins exclusivel)9 . . . .  
16 20 23 others only PTFE ' ' while others include both 
types of conduits  1-4"7"14"17'21'22'25'36 and even composite 
grafts. 24 All these differences in study settings and 
analysis may be enough to explain the variations in 
reported results. 
In 1986 the Adhoc Committee of the Society of 
Vascular Surgery 34 made an effort to provide some 
standards for published reports, however, it did not 
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make any strict recommendations for patient classifi- 
cation or for the definition of the types of arterial 
bypass. The report suggested that "it would be good 
to mention the inflow and outflow sites'. 34 This was 
fol lowed by some authors but not the majority, as 
shown in a recent comprehensive review. 31 The 
improved guidelines uggested in 1991, 35 which incor- 
porated pr imary assisted patency, did not make any 
improvements in respect to patient grouping and 
bypass type. 
In patient grouping, we think that the term "distal" 
is a misnomer and we recommend that "distal" should 
not be used. Single calf vessels should be classified as 
"crural" in order to avoid the term "tibial" which 
includes both the anterior and posterior tibial arteries 
but which can be taken to exclude the peroneal artery. 
(Crural literally means belonging to the leg, which 
clearly differentiates it anatomically from the thigh 
and the foot). It seems more appropriate to include 
grafts to the tibioperoneal trunk in the below-knee 
(BK) popliteal artery group, despite the fact that the 
former may be a worse recipient vessel. However, on 
theoretical grounds, 34 it represents a better outflow 
site than a single crural vessel. Further research is 
needed to clarify this but as most series report small 
numbers and the outcome is not reported separately it 
is extremely difficult to assess this issue by surveying 
the literature. 
To make the reasons for specific grouping more 
clear we present our own results from a 4 year 
experience of infrainguinal grafting for CLI, incorpo- 
rating both autologous vein and prosthetic material. 
The importance of the definition of "distal", the inflow 
and outflow sites in determining patency rates is 
Table 1. Review of patency rates reported for "distal" arterial bypass grafts. 
Years 1 2 3 4 5 Indication Conduit Bypass type 
Belkin, 1994 51 CI&CLI V&P Infrainguinal 
Secondary grafts 
80 CI&CLI V&P 
Primary grafts 
59 CI&CL1 
27 
79.8 CLI&C1 
66 
72 CLI&C1 
62 
32 
Belkin, 1995 
DeFrang, 1995 
Nehler, 1994 
Beard, 1989 
Rutherford, 1988 
Bartlett, 1987 
Loh, 1993 
Sayers, 1993 
Flinn, 1988 
Leather, 1988 
Taylor, 1992 
ECD, 1991 70 
40 
76 
64 
Ascer, 1987 39 
Veith, 1986 
37 
49 
29 12 
79 
54 
Christenson, 1985 39 
Dasing, 1985 65 
3O 
Wyatt, 1995 53 47 
Hehir, 1994 67 
Schweiger, 1993 52 42 
22 14 
Wolfe, 1991 52 
Feinberg, 1990 67 
3O 
Hobson, 1985 53 45 
20 12 
Tordoir, 1993 42 
78 60 
Panayiotopoulos, 1996 45 
PomposeUi, 1995 82 
Woelfle, 1993 86 72 
Wengerter, 1992 60 
Ascer, 1988 63 
CLI&C1 
CLI&C1 
CLI 
CLI 
CLI&C1 
CLI 
Primary 
Secondary 
CLI 
CLI 
CLI 
CLI 
CLI 
CLI 
CLI 
CLI 
InfrMnguinal 
V Infrainguinal 
P Infrainguinal 
V&P Infrainguinal 
V&P Infrainguinal 
V Infrainguinal 
V Infrainguinal 
V&P Infrainguinal 
P Infragenicular 
V Infragenicular 
P Infragenicular 
V Infragenicular 
P Infrapopliteal 
V Infrapopliteal 
P Infrapopliteal 
V&P Infrapopliteal 
V Infrapopliteal 
P Infrapopliteal 
P Infrapopliteal 
V Infrapopliteal 
P Infrapopliteal 
P&V Infrapopliteal 
V Crural 
P Crural 
P Crural 
P Crural 
V Crural 
P Crural 
V Crural 
P Crural 
P Crural/pedal 
V Crural/pedal 
V&P Crural/pedal 
V Short 
V Short 
V Short 
V Short 
CLI = critical imb ischaemia; C1 = claudication; V = vein; P = prosthetic material. 
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shown in Figs. 1-3. The dassi f icat ion of femor- 
opopl iteal  grafts or grafts to the t ib ioperoneal  t runk  as 
distal improves the results (51% at 4 years for 
infragenicular,  38.5% for infrapopliteal,  36% secon- 
dary patency at 3 years for femorocrura l /pedal ) .  
If further analysis is undertaken,  the differences 
become more evident (Fig. 2). Arterial bypass grafts to 
the above-knee (AK) popl i teal  have a 4 year patency 
rate of 64%, grafts to the BK popl iteal  67%, to the 
t ib ioperoneal  t runk  60%, whi le crural and  pedal  grafts 
have a secondary patency of 36% and 35 % respectively 
at 3 years. The signif icance of the inf low site is shown 
in Fig 3. Grafts or ig inat ing from the iliac arteries have 
a worse prognosis  (38% secondary patency at 2 years) 
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Fig. 1. Secondary patency according to the different definitions of "distal" bypass. The labels show the secondary patency at the end of the 
curve, the cumulative standard error and the percentage of censored grafts. ( . . . .  ) single crural 36.1%, S.E. -- 5.41 cens. 50%; (--)  
infrapopliteal 38.4%, S.E. = 5.21 cens. 50.4%; ( - - - )  infragenicular 51.3%, s.E. = 3.98 cens. 53.4%. 
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Fig. 2. The importance of the outflow site. The labels how the secondary patency at the end of the curve and the cumulative standard error. 
Outflow site: (--)  AK Popl. 64%, S.E. = 8.43; (- -  - -  - -)  BK Popl, 67%, S.E. = 5.76, (. . . .  ) Tib. trunk. 60% S.E. = 10.45, ( . . . . .  ) crural 36%, 
s.E. = 5.04; (...... ) pedal 35%, S.E. = 11.9. 
Eur J Vasc Endovasc Surg Vol 12, November 1996 
The Definition of "Distal" Bypass and "Secondary" Patency Rates 467 
g 
@ 
1.0 
0.9 
0.8 
0.7 
0.6 
0.5 
0.4 
0.3 
0.2 - 
0.1 - 
0.0 ~ 
-3 
1284 
- 27 H 
174 
-181 , _ ,~11 139 7 2 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
[ ~-~ 46 
_ 6 ~ _ _ _  i 
1 
I 
- L 
3 1 
I I E [ I , I~ , I , , Iq , I F , I , , I , , I , ,  r , l~ , l , , Iq , l , , I , , F , , I  
0 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 
Time (months) 
Fig. 3. The importance ofthe inflow site. The labels how the secondary patency at the end of the curve, the cumulative standard error and 
the percentage of censored grafts. Inflow site: (- - -) iliac 38%, S.E. = 15.38 cens. 55% (-) CFA 52.2%, s.E. = 4.04 cens, 65%; (. . . .  ) popl 73.2%, 
S.E. = 9.61 cens. 78%. 
compared to those from the popliteal artery (73% at 3 Inflow 1 and 
years), as the latter do not cross a joint, are short in Inflow 2 and 
length and are invariably vein grafts. Inflow 2 and 
All these problems hould be addressed in order to Inflow 2 and 
compare different series. Based on these observations Inflow 2 and 
we propose the following classification of lower limb Inflow 3 and 
bypass, which is based on division of the lower limb in Inflow 4 and 
6 levels and uses a combination of inflow and outflow 
sites: 
Lower limb levels 
Level 1 Suprainguinal arteries (aorta, common iliac, 
external iliac) 
Level 2 Common femoral, Proximal half of SFA, 
Profunda 
Level 3 Lower half of SFA and AK popliteal 
Level 4 BK popliteal and tibioperoneal trunk 
Level 5 Calf vessels 
Level 6 Pedal vessels 
Classification 
Inflow 1 and outflow 3Aorto/ i l io  above-knee 
popliteal 
Inflow 1 and outflow 4Aorto/ i l io  below-knee 
popliteal 
outflow 5 Aorto/i l iocrural 
outflow 3 Femoro above-knee popliteal 
outflow 4 Femoro below-knee popliteal 
outflow 5 Femorocrural 
outflow 6 Femoropedal 
outflow 4 or 5 Short crural bypass 
outflow 6 Popliteopedal bypass 
Inflow 4 or 5 and outflow 6 Short pedal bypass 
The grafts that cross four or more levels could then 
be defined as "long" while those crossing three levels 
or less could be grouped as "short" bypass grafts. 
The calf vessels pose a further problem, in that 
grafts to vessels in the proximal third may behave in a 
different way to the lower third of the calf arteries. 
More research needs to be performed into whether 
these grafts should be classified into separate cate- 
gories (2a proximal third, 2b middle third, 2c distal 
third). However, this subset may help to clarify the 
length of the graft. 
It seems appropriate to abandon the term "distal", 
however, if a single term is needed to group crural and 
pedal grafts, then the term "long femorocrural/pedal" 
bypass could be applicable, provided that only infra- 
popliteal grafts are analysed which cross at least four 
levels. The term "short crural /pedal" bypass could 
then be applicable to group both short crural and short 
pedal bypass grafts. 
The way the results are reported may also partially 
explain the variations between series. If authors use 
the Adhoc Committee recommendations, 34'35 patency 
rates are usually lower 2 than in publications which do 
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not. ~1 Some authors exclude immediate graft failures 
attributing them to technical error or poor patient 
selectiong'2s; however, these should all be included on 
an "intention to treat basis". If we exclude immediate 
failures, the results are dramatically improved in our 
series (Fig. 4), with a secondary patency rate of 52% at 
4 years increasing to 61% (p = 0.0026). 
The definition of primar~ primary assisted and 
secondary patency is more difficult. Primary patency 
is currently defined as uninterrupted patency with no 
procedures performed on the graft or its anasto- 
moses. 34 However, this definition allows more prox- 
imal (i.e. iliac angioplasty) or more distal procedures 
(i.e. short graft) to be performed, which will inevitably 
affect the patency rate of the original graft and, 
consequently, will alter its natural history. It would be 
better to include all these grafts associated with 
procedures performed on the proximal and distal 
vessels as primarily but assisted patency. Primary 
assisted patency is currently defined as uninterrupted 
patency but allows procedures performed on a patent 
graft (e.g. angioplasty, anastomotic revision etc.) to 
prevent subsequent thrombosis. 35However, if a jump 
graft is performed to a different outflow site while the 
original graft is still running, should this then be 
considered as primary assisted or secondary patency? 
Furthermore, if the jump graft goes to a different level 
which crosses a joint (e.g. from the popliteal to the 
tibial artery) should the patency be considered as 
primary assisted patency for the original above knee 
femoropopliteal bypass; or as secondary patency or 
finally as primary patency for a new femorotibial 
graft, censoring the original graft at that time interval 
as patent. This latter method will lead to an increase in 
the numbers of grafts performed per threatened 
limb. 
According to the Ad Hoc Committee of the Society 
of Vascular Surger]534"35 the definition of secondary 
patency implies that flow has stopped and has then 
been restored through most of the original graft, 
including at least one of its original anastomoses. This 
definition, although extremely helpful  is not strict. 
Flow restored by thrombolysis or thrombectomy with 
or without revision of one anastomosis certainly 
complies with it. However, other procedures may not. 
Such procedures are, firstly, thrombectomy with revi- 
sion of both anastomotic sites and, secondly, replace- 
ment of a small calibre vein by PTFE, preserving the 
two vein anastomoses as cuffs. If the latter is con- 
sidered to be secondary patency then the running 
graft would be PTFE while the original was vein. This 
would clearly affect the analysis. If a PTFE graft is 
replaced with vein, or if it is thrombectomised and 
vein cuffs are applied to both anastomoses, how 
should this procedure be classified? One further 
example is the situation in which a femoropopliteal 
PTFE graft is thrombectomised and the distal anasto- 
mosis revised, using the origin of the peroneal artery 
as the outflow site. The proximal anastomosis has 
been kept intact and flow has been restored through 
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Fig. 4. The difference in outcome when immediate failures are excluded from the analysis. The labels how the secondary patency at the 
end of the curve, the cumulative standard error and the percentage of censored grafts. (--) Excl. early failures 61%, s.E. = 4.17 cens. 75%; 
(---) all grafts 52%, s.~. = 3.79 cens. 65%. 
Eur J Vasc Endovasc Surg Vol 12, November 1996 
The Definition of "Distal" Bypass and "Secondary" Patency Rates 469 
most of the original graft, so theoretically it should be 
considered as secondary patency. However, the 
bypass is no longer a femoropopliteal bypass; it is a 
femorocrural graft and has a different natural history 
from the original one. The current guidelines are 
inadequate for the above examples. Consequently, the 
surgeon who performs the analysis is responsible for 
the definition of secondary patency. Some reports link 
secondary patency to the fate of the limb which dearly 
improves the results claimed as secondary patency. It
is our belief that limb salvage, although important 
from the patient's point of view should not be used as 
a measure of the result of arterial reconstruction. 
A further issue which is also extremely important is
the objective demonstration of graft patency. This 
should be performed by Duplex, Doppler ultrasound 
or angiography. Clinical improvement is an inade- 
quate index. 
One solution lies in reporting primary patency 
where no procedures can then be performed on that 
graft or its inflow and outflow vessels. The outcome of 
any further procedures on these vessels or the patent 
graft should be defined as primary assisted patency. 
The main problem lies with secondary patency. One 
alternative is to define this as limb salvage with a 
patent graft, irrespective of the number and type of 
procedures performed, as long as there is some graft 
segment left from the initial procedure. Secondary 
patency measures the efficacy of a vascular unit and is 
the only patency that is strongly associated with limb 
salvage, especially in cases of CLI. 
The other is to allow only some specific procedures 
to be undertaken, such as: 
1. Thrombolysis 
2. Thrombectomy 
3. Angioplasty revision of both anastomoses if the 
conduit remains the same 
4. Replacement of the conduit (with the same material) 
if both anastomoses are kept intact 
5. Distal extension (keeping the proximal anastomosis 
and most of the original conduct) only when the 
outflow site is at the same level as the original, i.e. 
without crossing a joint. The outflow levels are: (a) 
above-knee popliteal, (b) below-knee popliteal and 
tibioperoneal trunk, (c) crural vessels (tibial and 
personeal) and (d) pedal vessels 
6. Proximal extension, only if the inflow site is on the 
same level, without crossing a joint. CFA, SFA, and 
Profunda are considered to be on the same level. 
Suprainguinal inflow sites are a different inflow 
level. The above-knee popliteal should be also 
considered as a different inflow level to the below- 
knee popliteal artery. 
If these are not fulfilled, the graft should be 
censored and a new graft entered into the study. If the 
original is patent, this censoring should be for a 
running graft. If the graft has thrombosed but flow 
was established through the majority of it, this would 
also comply with censoring the graft as patent. 
However, if flow cannot be established through most 
of the graft or if only the proximal anastomosis is used 
for the new graft the original should then be censored 
as occluded (e.g. from our results patency for crural 
pedal grafts would then drop from 45 to 38% at 3 
years). 
In conclusion, this report further explores the 
anxieties expressed by Myers 31 and Underwood et 
al. 33 These authors highlighted the technical problems 
which derive from abuse of life table methods, such as 
the use of small samples, high censoring rate attrib- 
uted to death (with patency rates higher than the 
survival and foot salvage rates), poor audit systems, 
and superficial statistical analysis by doctors who do 
not fully appreciate the statistical requirements or 
statisticians who do not comprehend the implications 
of the results. We have shown that in addition to these 
there are other issues which do not allow fair 
comparison between different series and may give an 
incorrect impression regarding the natural history of 
the graft. Even if we assume that all reports comply 
with the recommendations of the Vascular Commit- 
tees, problems till persist. Some consensus needs to 
be found on both the strict definition of secondary 
patency and the type of graft based on the inflow and 
outflow sites. The world "distal" should be aban- 
doned as it is open to wide interpretations. 
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